Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Oceanic Iron Ore Corp New
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
(CSE:
VLAB
)
1.700
+0.200 (+13.33%)
Delayed Quote
Updated: 12:55 PM EST, Nov 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about VLAB
Vesalius Longevity Labs Appoints Longevity Entrepreneur Dr. Peter Diamandis to Its Board of Directors
Today 9:28 EST
(November 19, 2026) - Vesalius Longevity Labs Inc. (CSE:VLAB) ("Vesalius" or the "Company"), a leading global peptide and longevity company, is pleased to announce the
Via
PressReach
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
Today 8:45 EST
GLP-1 Treatments, Anticancer Research, and Emerging Therapeutic Technologies Are Driving the Next Chapter of Pharmaceutical Innovation
From
FN Media
Via
GlobeNewswire
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
Today 8:35 EST
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:LLY),(NYSE:HIMS),(TSXV:PAIN),(CSE:VLAB) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.